This is a Competitive renewal application for the P30-supported Cincinnati Rheumatic Diseases Core Center (CRDCC). The overall goal of the CRDCC is to promote biomedical research that yields insights into fundamental processes and pathogenic mechanisms of rheumatic diseases in children, which can lead to innovative treatments for these diseases.
The aims of the CRDCC are to foster this research and promote interdivisional and interdepartmental collaborations, with a focus on translational opportunities. CRDCC-supported projects have great potential to advance the national research agenda related to rheumatic diseases, and represent an area of tremendous strength and resource investment at Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine. The CRDCC offers four innovative research cores, including Pediatric Rheumatology Tissue Repository Core, Animal Models Core, Integrative Cell Phenotyping and Morphology Core, and Bioinformatics Core. Collectively, these Cores form a powerful infrastructure that fosters development of personalized and predictive medical approaches based on genomics and disease mechanisms. The CRDCC supports disease based research across the continuum of discovery, where laboratory findings generate translational studies that lead to clinical trials. In addition to advancing knowledge of pediatric rheumatic disease, the goals of the CRDCC include recruitment of established investigators to bring new expertise to the field, cultivation of collaborations among Research Base investigators, and encouragement of young investigators committed to pursuing research careers focused on pediatric rheumatic disease. These goals of the CRDCC are particularly supported by a Pilot &Feasibility Study Program that will transcend the Cincinnati Research Base to include pediatric rheumatology investigators across the US. The CRDCC also will improve the Cincinnati Research Base through an enrichment program of local seminars, workshops and symposia. The success of the CRDCC is evidenced by productivity of the Research Base, the extensive scope of ongoing collaborations, and the Research Base's record of receiving funding for cutting edge research related to pediatric rheumatic disease. These past accomplishments are likely to be strongly predictive of the future success of CRDCC-supported research.

Public Health Relevance

The Cincinnati Rheumatic Diseases Core Center will promote biomedical research that yields insights into fundamental processes and pathogenic mechanisms of rheumatic diseases in children. This will be done by coordinating research core services and promoting interdivisional and interdepartmental collaborations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
2P30AR047363-11
Application #
8136376
Study Section
Special Emphasis Panel (ZAR1-MLB (M1))
Program Officer
Wang, Yan Z
Project Start
2001-03-15
Project End
2016-06-30
Budget Start
2011-08-25
Budget End
2012-06-30
Support Year
11
Fiscal Year
2011
Total Cost
$602,635
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
McNally, Jonathan P; Millen, Scott H; Chaturvedi, Vandana et al. (2017) Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases. Proc Natl Acad Sci U S A 114:E4782-E4791
Hinks, A; Bowes, J; Cobb, J et al. (2017) Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases. Ann Rheum Dis 76:765-772
Chimote, Ameet A; Hajdu, Peter; Sfyris, Alexandros M et al. (2017) Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer. Cancer Res 77:53-61
Feldhoff, Lea M; Rueda, Cesar M; Moreno-Fernandez, Maria E et al. (2017) IL-1? induced HIF-1? inhibits the differentiation of human FOXP3+ T cells. Sci Rep 7:465
McKnight, Christopher G; Jude, Joseph A; Zhu, Zhenqi et al. (2017) House Dust Mite-Induced Allergic Airway Disease Is Independent of IgE and Fc?RI?. Am J Respir Cell Mol Biol 57:674-682
Ombrello, Michael J; Arthur, Victoria L; Remmers, Elaine F et al. (2017) Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis 76:906-913
Smith, Eric A; Gole, Boris; Willis, Nicholas A et al. (2017) DEK is required for homologous recombination repair of DNA breaks. Sci Rep 7:44662
Lo, Yuan-Hung; Chung, Eunah; Li, Zhaohui et al. (2017) Transcriptional Regulation by ATOH1 and its Target SPDEF in the Intestine. Cell Mol Gastroenterol Hepatol 3:51-71
Thornton, Sherry; Raghu, Harini; Cruz, Carolina et al. (2017) Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cells. Blood Adv 1:545-556
Rueda, Cesar M; Rodríguez-Perea, Ana Lucia; Moreno-Fernandez, Maria et al. (2017) High density lipoproteins selectively promote the survival of human regulatory T cells. J Lipid Res 58:1514-1523

Showing the most recent 10 out of 206 publications